Using a large number of breast cancer cases identified from the Nurses’ Health Study, Liu et al. found that the VEGF-A associated adverse effects on breast cancer specific mortality and distant recurrence was only observed in luminal A tumors and not in luminal B, HER2-positive and basal-like/triple-negative cancers(29). The gene discussed is VEGFA; the disease is breast carcinoma.